Form 10-Q Inari Medical, Inc. For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- US futures fall on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Inari Medical Inc. (NARI) PT Raised to $50 at Truist Securities
October 29, 2024 5:57 AM EDTTruist Securities analyst Richard Newitter raised the price target on Inari Medical Inc. (NASDAQ: NARI) to $50.00 (from $46.00) while maintaining a Hold rating.
The analyst comments "NARI's 3Q profit beat shld help the stock recover a bit (up +9% AMC) some of its recent pullback... More
BTIG Reiterates Buy Rating on Inari Medical Inc. (NARI)
October 29, 2024 5:47 AM EDTBTIG analyst Marie Thibault reiterated a Buy rating and $86.00 price target on Inari Medical Inc. (NASDAQ: NARI).
The analyst comments "Inari Medical reported Q3 revenue of $153.4M (+21.4% y/y and +5% sequentially), above consensus of $150.7M. NARI had previously set a Q3 sales outlook that implied ~$150M this ~$3M beat vs our expectations was driven by U.S. VTE and International sales growth. The full-year revenue outlook was... More
